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Background: The metabolism and excretion of the anabolic steroid testosterone occurs by glucuronidation to the
conjugate testosterone glucuronide which is then excreted in urine. Alterations in UGT glucuronidation enzyme
activity could alter the rate of testosterone excretion and thus its bioavailability. The aim of this study is to
investigate if red wine, a common dietary substance, has an inhibitory effect on UGT2B17.
Methods: Testosterone glucuronidation was assayed using human UGT2B17 supersomes with quantification of
unglucuronidated testosterone over time using HPLC with DAD detection. The selected red wine was analyzed
using HPLC; and the inhibitory effects of the wine and phenolic components were tested independently in a
screening assay. Further analyses were conducted for the strongest inhibitors at physiologically relevant
concentrations. Control experiments were conducted to determine the effects of the ethanol on UGT2B17.
Results: Over the concentration range of 2 to 8%, the red wine sample inhibited the glucuronidation of
testosterone by up to 70% over 2 hours. The ethanol content had no significant effect. Three red wine phenolics,
identified by HPLC analyses, also inhibited the enzyme by varying amounts in the order of quercetin (72%), caffeic
acid (22%) and gallic acid (9%); using a ratio of phenolic:testosterone of 1:2.5. In contrast p-coumaric acid and
chlorogenic acid had no effect on the UGT2B17. The most active phenolic was selected for a detailed study at
physiologically relevant concentrations, and quercetin maintained inhibitory activity of 20% at 2 μM despite a
ten-fold excess of testosterone.
Conclusion: This study reports that in an in vitro supersome-based assay, the key steroid-metabolizing enzyme
UGT2B17 is inhibited by a number of phenolic dietary substances and therefore may reduce the rate of
testosterone glucuronidation in vivo. These results highlight the potential interactions of a number of common
dietary compounds on testosterone metabolism. Considering the variety of foodstuffs that contain flavonoids, it is
feasible that diet can elevate levels of circulating testosterone through reduction in urinary excretion. These results
warrant further investigation and extension to a human trial to delineate the health implications.
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Numerous reports have attested to the health damaging
effects of red wine and its components beyond excess al-
cohol consumption, for example - owing to pesticide
and heavy metal content [1,2]. In contrast, many reports
point to the health protective effects of red wine owing
to the abundance of anti-oxidants [3,4]. Beyond modu-
lating oxidative damage, one focus has been on the fe-
male endocrine system, following the reports that red* Correspondence: D. Naughton@kingston.ac.uk
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reproduction in any medium, provided the orwine has anti-aromatase properties [5]. This discovery
broadened the debate regarding the link between alcohol
intake and risk of developing breast cancer [6,7].
Equally, the associations of high and low testoster-
one levels with the development of various forms of
prostate cancer have been subjected to considerable
debate [8-10]. Given the inhibitory effects of red
wine on aromatase it is conceivable that red wine
also affects aspects of testosterone metabolism. Al-
though recent epidemiological studies have suggested
red wine consumption is not a potential risk factorral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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testosterone metabolism warrant investigation.
Glucuronidation is a major metabolic pathway for the
elimination of testosterone and numerous compounds
from the body [13,14]. Glucuronidation of testosterone
involves the transfer of a glucuronosyl group from UDP-
glucuronic acid (UDPGA) to form the steroid conjugate,
testosterone glucuronide, which is then excreted in urine
[13]. The UDP-glucuronosyltranferase UGT2B17 en-
zyme is the main steroid glucuronidation enzyme of the
UGT isotopes with more than double the glucuronida-
tion activity compared to the second most active enzyme
involved in glucuronidation of testosterone, UGT2A1
[15].
The metabolism of testosterone by UGT2B17 has been
shown to differ between individuals owing to the varia-
tions in the expression of UGT2B17, which has been
found to alter with ethnicity, affecting the excreted ster-
oid concentrations [16]. In in vitro studies, the rate of
testosterone glucuronidation has also been shown to be
reduced with inhibitors of UGT2B17, such as non-ster-
oidal anti-inflammatory drugs [15]. Whilst various drugs
and compounds are glucuronidated as a substrate and
inhibit UGT2B17 [13], little is known about the inhibi-
tory effects common dietary substances could have on
UGT2B17 and testosterone glucuronidation.
Recently, green and white teas and purified catechin
constituents have been shown to inhibit the key testos-
terone glucuronidation enzyme UGT2B17 in a
supersome-based assay [17]. Red wine is another rich
source of phenolic compounds that have been found to
exert anti-oxidant health benefits in humans [18]. Given
the inhibitory effects of green and white tea on
UGT2B17, along with the debate on red wine and pros-
tate cancer, it is timely to investigate if phenolic com-
pounds in red wine have an inhibitory effect on
testosterone metabolism and excretion.
The aim of this study was to analyze the inhibitory
effects of a dietary red wine sample and the common
phenolic compounds found in red wine, independent of
the effects of alcohol, on the glucuronidation of testos-
terone through the inhibition of UGT2B17. A further
aim was to study the potential inhibitory effect of the
common wine by-product 4-ethylphenol on testosterone
glucuronidation.
Materials and methods
Materials
Testosterone, acetonitrile, ethanol, gallic acid, chlorogenic
acid, caffeic acid and quercetin were purchased from Sigma
Aldrich (Poole, United Kingdom). Dimethyl sulfoxide,
methanol and high performance liquid chromatography
(HPLC) grade water were purchased from Fisher Scientific.
The UGT2B17 enzymes where purchased as humanUGT2B17 supersomes from BD Biosciences. UDPGA was
purchased as a UGT reaction solution (mixture A) from
BD Biosciences. The MgCl2 and Tris–HCl buffers, along
with alamethicin were purchased together as a UGT reac-
tion mixture (solution B) from BD Biosciences. The red
wine sample used was a Cabernet-Syrah red wine pur-
chased from a local supermarket (London). All solvents
used where HPLC grade.
Methods
For general screening, HPLC analysis of testosterone
glucuronidation was conducted on an Agilent 1260
HPLC system using an Ascentis Supelco C18 column,
25 cm x 406 mm i.d., 5 μM at 25°C column temperature.
The mobile phase was methanol and water (80:20) at a
flow rate of 1 mL/min and a 100 μL injection volume.
The remaining testosterone from the reactions was
detected by UV detection at 246 nm using a diode array
detection system. The results represent the SD of dupli-
cate values.
To assay the effects of quercetin at low concentrations,
an alternate highly sensitive HPLC method was adopted
to analyze testosterone [19]. Testosterone was dissolved
in acetonitrile and added as 1% v/v. The mobile phase
was acetonitrile/water (39/61, v/v) at a flow rate of
1 mL/min. The injection volume was 50μL and detec-
tion at 245 nm. The results represent the SD of triplicate
values.
The testosterone glucuronidation assay, described
in the BD biosciences data sheet for the human
UGT2B17 supersomes, employs a standard incuba-
tion mixture containing UDPGA (2 mM), alamethi-
cin (25 μg/mL), magnesium chloride (8 mM) and pH
7.5 Tris–HCl buffer (50 mM) and deionised water
comprising 50% of the overall reaction volume.
Following incubation at 37°C for five minutes, the
reaction was initiated by the addition of 0.2 mg/mL
ice cold UGT2B17 supersomes. The reactions were
stopped by the transfer of 100 μL aliquots to 100 μL
ice cold acetonitrile, vortex-mixed with samples
stored on wet ice. The samples were centrifuged at
10,000 x g for 5 minutes. The aliquots of the super-
natants were then analyzed by HPLC.
In order to study the inhibitory effects of red wine,
various volumes ranging from 2-8% of red wine were
added to the reaction. The reactions were stopped after
one or two hours and the remaining testosterone was
analyzed to determine any increase in testosterone
through the inhibition by red wine. The red wine sample
had been evaporated to dry residue to remove the etha-
nol and reconstituted with the same volume of water
and filtered by a Millex 0.45 μM filter device.
The phenolic compounds gallic acid, caffeic acid and
quercetin that are present in red wine were analyzed for
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(250 μM) were dissolved in ethanol and heated and
mixed to aid dissolving where necessary and added to
the reaction as 1% v/v of the reaction. The phenolic
compound 4-ethylphenol was dissolved in ethanol and
added to the reaction at 1% of the overall reaction vol-
ume at 750 μM overall concentration. The reaction dur-
ation was for 1 hour.
The red wine sample used in the glucuronidation
assays was analyzed to determine the phenolic com-
pounds present in the wine. The wine sample for HPLC
analysis was prepared by evaporating the sample to dry-
ness with the remaining dry residue dissolved in water
to restore the original volume of the sample. The sample
was then filtered by a Millex 0.45 μM filter device and
injected into the HPLC. Quantification was performed
as previously described [20] on an Agilent 1260 HPLC
using a Kromasil C18 column, 250 mm x 406 mm 5 μM
with detection at 280 nm. The mobile phase consisted of
0.1% orthophosphoric acid in water (A) and methanol
(B). The mobile phase gradient elusions were (80% A:
20% B) 0 minutes, (60% A: 40% B) 10 minutes, (50% A:
50% B) 20 minutes, (45% A: 55% B) 30 minutes, (35% A:
65% B) 50 minutes. The flow rate was 1 mL/min with a
10 μL injection volume. Phenolic standards were dis-
solved in water at a concentration of 1 mg/mL and indi-
vidually injected into the HPLC under the same
conditions with the retention times compared to that of
the red wine sample to indentify each phenolic
compound.
Statistical analyses were conducted using SPSS v19.
The significance of reduction in glucuronidation activity
was tested for using a directional one-sample t-test (Ha:
activity <100%) with the significance level set at 0.05.
Mixed model ANOVA was used to test for statistically
significant difference over time and between concentra-
tions, including testing for interaction effect.
Results
Inhibitory effects of red wine on UGT2B17
The effects of increasing concentrations of red wine on the
UGT2B17-mediated glucuronidation of testosterone were
assessed as a function of the reduction in conversion of
testosterone to testosterone glucuronide (Figure 1). The
results show that increasing the concentration of red wine
resulted in a lower conversion of testosterone to its glucur-
onide conjugate. A reduction in UGT2B17 activity was
observed for all, ranging between ca 10% to over 70% over
two hours for additions of 2% to 8% red wine (p=0.01;
0.002; 0.008 and 0.014 over one hour and p=0.019; 0.033;
0.008 and 0.007 over two hours, respectively for 2%, 4%,
6% and 8%). The percentage of ethanol present in the final
assay was in the range of 0.26% - 1.04% corresponding to
additions of red wine at 2% - 8% respectively. It is notablethat during a 2 hour period the inhibition is more pro-
nounced at higher concentration of the red wine. Statisti-
cally significant differences were evidenced between times
(p= 0.028) and concentrations (p < 0.001), with significant
interaction between the two (p=0.001).
The effect on UGT2B17 activity by the addition of an
evaporated red wine sample reconstituted with an equal
volume of water at concentrations of 4% and 8% of the
reaction volume resulted in a glucuronidation % of con-
trol at 59.18 ± 3.154 and 23.48 ± 4.405, respectively.
These values, taken after a two-hour duration, resemble
those from the intact wine samples (Figure 1) indicating
minimal contributions from the ethanol content on the
inhibition of UGT2B17 by red wine.
The effects of increasing concentrations of ethanol on
the reduction of testosterone by UGT2B17 are shown in
Figure 2. The results indicated that testosterone glucuro-
nidation was only slightly altered by ethanol at a 1%
concentration (p = 0.353); however as the concentration
of ethanol was increased to above 2% of the reaction vol-
ume, testosterone glucuronidation was affected as shown
but not reaching a statistically significant level (p = 0.134
and 0.110 for 2% and 3%, respectively).Analysis of red wine
In order to identify individual inhibitors of UGT2B17,
the phenolic content in the wine sample was investigated
by HPLC. Analysis of the red wine confirmed the pres-
ence of gallic acid, chlorogenic acid, caffeic acid, p-
coumaric acid and quercetin (Figure 3), which informed
subsequent experiments.The inhibitory effect of individual phenolic compounds
Initial experiments were performed to screen the pheno-
lics found in red wine for their effects on UGT2B17.
Table 1 shows the effect on the glucuronidation activity
of testosterone when 250 μM of each of the three phen-
olic compounds found in the red wine sample were
added separately to the reaction over 60 minutes. Apart
from chlorogenic and p-coumaric acids glucuronidation
activity was reduced by each of the compounds in vary-
ing degrees. The inhibitory action of 4-ethylphenol is
also displayed in Table 1. The results show the reduction
in testosterone glucuronidation at initial testosterone
concentrations of 100 μM, 50 μM and 20 μM.
Quercetin was selected from the initial high concentra-
tion screening assay for further study as it exhibited the
highest level of inhibition at 72%. Reducing the testosterone
levels to 20 μM resulted in inhibition of 34-18% by a low
concentration of quercetin, in a concentration dependent
manner, despite the 10-fold excess in testosterone levels
(Table 1). In addition, for a quercetin concentration of
2 μM, increasing testosterone levels to 30 μM resulted in a
Figure 1 Reduction of testosterone glucuronidation in the presence of red wine at 100 μM initial testosterone. The results display the SD
values of duplicate samples.
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mechanism is by competitive inhibition.
Discussion
This report extends the previous study which demon-
strated that tea and its component flavones competi-
tively inhibit testosterone glucuronidation by
UGT2B17. The results of this study showed that
phenolic compounds commonly found in red wine,
but also in many other foods, have comparable effect
on testosterone glucuronidation. The rate of glucuro-
nidation was similar on addition of the wine sampleFigure 2 Effect of ethanol on the testosterone glucuronidation by UG
of testosterone was measured at the end of the reaction which was termin
samples.once the ethanol had been removed, indicating that
it was likely to be the phenolic compounds that
caused inhibition. Further studies revealed that etha-
nol had no effect at the concentrations found in the
added wine sample. However, at higher concentra-
tions of ethanol (>1%) the UGT2B17 enzyme activity
was reduced. Ethanol has been linked to increased
testosterone and aggression in male hamsters [21]
and increased testosterone in rat brain [22]. From
our results, the effects of alcohol on UGT2B17 are
unlikely to account for the increase in testosterone,
unless extremely high doses are consumed.T2B17, based on the concentration of testosterone. Concentration
ated after 30 minutes. The results display the SD values of duplicate
Figure 3 Chromatogram showing the phenolic compounds present in the red wine sample. 1. Gallic acid, 2. Chlorogenic acid, 3. Caffeic
acid, 4. p-Coumaric acid, 5. Quercetin.
Jenkinson et al. Nutrition Journal 2012, 11:67 Page 5 of 7
http://www.nutritionj.com/content/11/1/67Several of the individual wine phenolic compounds
inhibited the glucuronidation of testosterone at different
efficiencies. The maximum inhibition was observed for
quercetin, followed by 4-ethylphenol and caffeic acid.
The serum concentrations of phenolic compounds that
are commonly found in wine can be increased through
supplementation such as with quercetin [23]. In one
study, after supplementation, 1.5 μM quercetin levels in
plasma were reported [24]. This concentration of quer-
cetin affected a 9% reduction in UGT2B17 activity des-
pite a high concentration of testosterone at 20 μM. The
reported mean level of serum testosterone in adult males
is 35.9 nM [25]. Given the inhibition is competitive;Table 1 Reduction in testosterone glucuronidation activity of
Initial testosterone concentration (μM) Test sample concentration T
Screening study
100 4-Ethylphenol
50 4-Ethylphenol
100 Gallic acid
100 Caffeic acid
100 p-Coumaric Acid
100 Chlorogenic Acid
100 Quercetin
Low concentration study
20 Quercetin
20 Quercetin
20 Quercetin
30 Quercetin
20 Quercetin
The results display the percentage change in the glucuronidation of testosterone othese much lower concentrations of testosterone should
result in higher inhibition of UGT2B17 by quercetin. Fu-
ture studies are warranted to investigate the effects of
red wine and its components at physiological levels of
testosterone.
In addition, plasma concentrations of caffeic acid have
been shown to increase after the consumption of red wine
[26]. Given these increases in serum concentrations
through supplementation it may be possible to further re-
duce testosterone metabolism through glucuronidation.
The phenolic compound 4-ethylphenol has been found
in red wines to produce distinct aromas [27], as well as
being produced by the spoilage of yeast, hence it can beUGT2B17 by the addition of phenolic compounds
est sample concentration (μM) Glucuronidation % of control (±SD)
750 78.9 ±1.131
750 57.3 ±13.548
250 91.01 ±10.946
250 78.65 ±5.685
250 NA
250 NA
250 28.01 ±2.800
50 65.62 ±14.298
20 79.93 ±11.370
2 82.42 ±7.057
2 97.69 ±9.235
1.5 91.37 ±7.806
ver 60 mins by UGT2B17 in comparison to the uninhibited control.
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ingly or unknowingly into the diet. 4-Ethylphenol has
also been shown here to inhibit the glucuronidation of
testosterone through the UGT2B17 enzyme. The inhib-
ition of UGT2B17 by 4-Ethylphenol was found to be
greater at the lower 50 μM level of testosterone. How-
ever, at high initial testosterone concentrations above
150 μM there was very little or no inhibition showing
that increasing the concentration of testosterone will
overcome the inhibiting compound. 4-Ethylphenol has
been shown to be a substrate for UGT2B17 with a glu-
curonide being formed [13]; therefore it is likely that
these compounds are acting competitively with the
UGT2B17 enzyme.
Whilst it has been found that no correlation exists be-
tween the variations of the UGT2B17 genotype with
alterations in circulating serum testosterone levels [29-
31], another study has found significant differences in
circulating testosterone with an increase in individuals
expressing no copy number of UGT2B17 compared to
individuals with one or two copies of UGT2B17 [32]. It
has yet to be determined if any direct inhibition of ster-
oid glucuronidation enzymes could alter the levels of cir-
culating serum testosterone in addition to altering the
levels of testosterone excreted in urine. These results
augment the previous study revealing that tea catechins
can inhibit testosterone metabolism by supersomes con-
taining UGT2B17 [17]. The ubiquitous presence of quer-
cetin and other active flavonols, along with the
catechins, in many foodstuffs indicate that any in vivo
effects may be common. These effects, if found to occur
in vivo, may have a pronounced effect on people with
endocrine disorders or very low levels of endogenous
testosterone, owing to high levels of receptor expression
to compensate. A further aspect, although not studied
here, is the potential interaction of quercetin-containing
foodstuffs with drug metabolism as some drugs are
metabolized via the action of UGT2B17 [33].
In conclusion it has been found that a commonly con-
sumed dietary substance, red wine along with phenolic
compounds present in red wine, inhibit testosterone glu-
curonidation. These results have also shown that al-
though some of these compounds are not substrates of
UGT2B17 they can inhibit the enzyme in supersomes.
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